Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Proc Natl Acad Sci U S A ; 115(22): E5243-E5249, 2018 05 29.
Article in English | MEDLINE | ID: mdl-29760065

ABSTRACT

NF-κB signaling plays a pivotal role in control of the inflammatory response. We investigated how the dynamics and function of NF-κB were affected by temperature within the mammalian physiological range (34 °C to 40 °C). An increase in temperature led to an increase in NF-κB nuclear/cytoplasmic oscillation frequency following Tumor Necrosis Factor alpha (TNFα) stimulation. Mathematical modeling suggested that this temperature sensitivity might be due to an A20-dependent mechanism, and A20 silencing removed the sensitivity to increased temperature. The timing of the early response of a key set of NF-κB target genes showed strong temperature dependence. The cytokine-induced expression of many (but not all) later genes was insensitive to temperature change (suggesting that they might be functionally temperature-compensated). Moreover, a set of temperature- and TNFα-regulated genes were implicated in NF-κB cross-talk with key cell-fate-controlling pathways. In conclusion, NF-κB dynamics and target gene expression are modulated by temperature and can accurately transmit multidimensional information to control inflammation.


Subject(s)
Gene Expression Regulation/physiology , NF-kappa B/metabolism , Tumor Necrosis Factor alpha-Induced Protein 3/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Cell Line, Tumor , Cells, Cultured , Cytokines/metabolism , Gene Expression Regulation/genetics , Gene Knockdown Techniques , Humans , Inflammation , Mice , NF-kappa B/genetics , Signal Transduction/genetics , Signal Transduction/physiology , Temperature , Tumor Necrosis Factor alpha-Induced Protein 3/analysis , Tumor Necrosis Factor alpha-Induced Protein 3/genetics
2.
Osteoarthritis Cartilage ; 23(11): 1981-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26521744

ABSTRACT

OBJECTIVE: To define how the catabolic cytokines (Interleukin 1 (IL-1) and tumor necrosis factor alpha (TNFα)) affect the circadian clock mechanism and the expression of clock-controlled catabolic genes within cartilage, and to identify the downstream pathways linking the cytokines to the molecular clock within chondrocytes. METHODS: Ex vivo cartilage explants were isolated from the Cry1-luc or PER2::LUC clock reporter mice. Clock gene dynamics were monitored in real-time by bioluminescence photon counting. Gene expression changes were studied by qRT-PCR. Functional luc assays were used to study the function of the core Clock/BMAL1 complex in SW-1353 cells. NFкB pathway inhibitor and fluorescence live-imaging of cartilage were performed to study the underlying mechanisms. RESULTS: Exposure to IL-1ß severely disrupted circadian gene expression rhythms in cartilage. This effect was reversed by an anti-inflammatory drug dexamethasone, but not by other clock synchronizing agents. Circadian disruption mediated by IL-1ß was accompanied by disregulated expression of endogenous clock genes and clock-controlled catabolic pathways. Mechanistically, NFкB signalling was involved in the effect of IL-1ß on the cartilage clock in part through functional interference with the core Clock/BMAL1 complex. In contrast, TNFα had little impact on the circadian rhythm and clock gene expression in cartilage. CONCLUSION: In our experimental system (young healthy mouse cartilage), we demonstrate that IL-1ß (but not TNFα) abolishes circadian rhythms in Cry1-luc and PER2::LUC gene expression. These data implicate disruption of the chondrocyte clock as a novel aspect of the catabolic responses of cartilage to pro-inflammatory cytokines, and provide an additional mechanism for how chronic joint inflammation may contribute to osteoarthritis (OA).


Subject(s)
Chondrocytes/metabolism , Circadian Clocks/genetics , Cytokines/genetics , DNA/genetics , Gene Expression Regulation , NF-kappa B/genetics , Osteoarthritis/genetics , Animals , Cartilage, Articular/metabolism , Cartilage, Articular/pathology , Cells, Cultured , Cytokines/biosynthesis , Disease Models, Animal , Mice , Mice, Transgenic , NF-kappa B/biosynthesis , Osteoarthritis/metabolism , Osteoarthritis/pathology , Reverse Transcriptase Polymerase Chain Reaction
3.
Endocrinology ; 149(2): 687-94, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18006630

ABSTRACT

Estrogens have been implicated in the regulation of prolactin gene expression in man, although previous studies have not defined the molecular mechanism whereby estradiol activates the human prolactin gene promoter (hPrl). We found that estradiol induced a reproducible 1.8-fold activation of the hPrl gene promoter, using pituitary GH3 cells stably transfected with a 5000-bp hPrl promoter fragment linked to luciferase reporter gene. This activation was blocked by treatment with estrogen receptor (ER) antagonists 4-hydroxytamoxifen and ICI-182,780. Promoter deletion and mutagenesis experiments identified a functional estrogen response element (ERE) sequence 1189 bp upstream of the transcription start site that was responsible for estrogen-mediated promoter activation. This site differed from the consensus ERE sequence by two base pairs, one in each half-site. This ERE was identified to be functional through binding ERalpha in EMSAs. Chromatin immunoprecipitation assays confirmed ERalpha binding to this sequence in vivo in the absence of ligand, with increased recruitment when cells were cultured in the presence of estradiol. When cells were treated with both estradiol and TNFalpha, we observed synergistic activation of the hPrl promoter, which was mediated by the -1189-bp ERE. Mutagenesis of this ERE abolished the promoter-activating effect not only of estradiol but also of TNFalpha. These data suggest a novel, promoter-specific signaling interaction between estrogen and TNFalpha signaling, which is likely to be important for prolactin regulation in vivo.


Subject(s)
Estradiol/metabolism , Prolactin/genetics , Signal Transduction/physiology , Tumor Necrosis Factor-alpha/metabolism , Animals , Cell Line , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Fulvestrant , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Humans , Luciferases/genetics , Pituitary Gland, Anterior/cytology , Promoter Regions, Genetic/physiology , Rats , Rats, Inbred F344 , Receptors, Estrogen/metabolism , Signal Transduction/drug effects , Tamoxifen/analogs & derivatives , Tamoxifen/pharmacology
4.
Mol Endocrinol ; 17(2): 193-202, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12554747

ABSTRACT

Real-time imaging of the GH gene promoter linked to luciferase in living pituitary cells has revealed surprising heterogeneity and variety of dynamic patterns of gene expression. Cells treated with either forskolin or thyroid hormone generated a consistent and characteristic temporal response from cell populations, but detailed analysis of individual cells revealed different patterns. Approximately 25-26% of cells displayed no response, 25-33% of cells exhibited a sustained progressive rise in luciferase activity, and 41-50% showed a transient phasic, or oscillatory response, after given stimuli. In cells treated consecutively with the two stimuli, the population response to the second stimulus was augmented. Single-cell analysis revealed that this was partly due to an increased number of cells responding, but also that the prevalence of response patterns changed: cells that responded to an initial stimulus were more likely to respond subsequently in a progressive sustained manner. In conclusion, these studies have indicated that GH promoter activity in individual living pituitary cells is unstable and possibly stochastic, with dynamic variations from hour to hour. The prevalence of different temporal patterns of response to hormonal stimulation among a population of cells is altered by the endocrine history of those cells.


Subject(s)
Human Growth Hormone/genetics , Human Growth Hormone/metabolism , Pituitary Gland/cytology , Pituitary Gland/physiology , Transcription, Genetic , Animals , Cells, Cultured , Colforsin/pharmacology , Cyclic AMP/pharmacology , Human Growth Hormone/drug effects , Humans , Luciferases/drug effects , Luciferases/genetics , Luciferases/metabolism , Pituitary Gland/drug effects , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Time Factors , Triiodothyronine/pharmacology
5.
Integr Biol (Camb) ; 7(6): 713-25, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25990200

ABSTRACT

Live-cell imaging of fluorescent fusion proteins has transformed our understanding of mammalian cell signalling and function. However, some cellular systems such as immune cells are unsuitable or refractory to many existing transgene delivery methods thus limiting systematic analyses. Here, a flexible lentiviral gene transfer platform for dynamic time-lapse imaging has been developed and validated with single-molecule spectroscopy, mathematical modelling and transcriptomics and used for analysis of a set of inflammation-related signalling networks. Time-lapse imaging of nuclear factor kappa B (NF-κB), signal transducer and activator of transcription (STATs) and nuclear factor of activated T-cells (NFAT) in mammalian immune cell lines provided evidence for heterogeneous temporal encoding of inflammatory signals. In particular, the absolute quantification of single-cell responses over time via fluorescent correlation spectroscopy (FCS) showed that NF-κB p65 activation in response to tumour necrosis factor α (TNFα) was differentially encoded in variable amplitude of nuclear translocation between immune and non-immune cells. The absolute number of activated molecules was dictated in part by the cell size, suggesting a morphology-dependent regulatory mechanism. The developed platform will enable further absolute quantitative analyses of the dynamic interactions between signalling networks, in and between individual cells, allowing better integration with mathematical models of signalling networks.


Subject(s)
Gene Transfer Techniques , Immune System/cytology , Immune System/metabolism , Lentivirus/genetics , Time-Lapse Imaging/methods , Animals , Cell Line , HEK293 Cells , Humans , Immune System Phenomena/genetics , Jurkat Cells , Mice , Microscopy, Confocal , Models, Immunological , NFATC Transcription Factors/genetics , RAW 264.7 Cells , STAT Transcription Factors/genetics , Signal Transduction/genetics , Signal Transduction/immunology , Single-Cell Analysis/methods , Transcription Factor RelA/genetics
6.
J Endocrinol ; 178(1): 61-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12844337

ABSTRACT

Although analysis of luciferase activity using luminescence imaging has provided new insights into the dynamic regulation of gene expression in living tIssues, studies in vitro have relied on stably transfected clonal cell lines, limiting the choice of cell type and species, or DNA microinjection, which is arduous and highly selective. We report here the first use of a recombinant adenovirus in which the firefly luciferase reporter gene was regulated by the prolactin gene promoter, to study temporal dynamics of promoter activity. This vector was used to infect the pituitary GH3 cell line, and also primary cultures of Syrian hamster pituitary cells. We show that adenovirally transduced cells retained normal regulation of the promoter-reporter transgene by appropriate signals. Furthermore, microscopic imaging studies indicated that both clonal and primary pituitary cells were transduced efficiently, giving readily detectable luminescence signals in real-time over long periods. Finally, analysis of single-cell expression patterns indicated that prolactin promoter activity was highly dynamic with pulses in gene expression, revealing that the transcriptional instability seen in clonal cells is a feature of normal pituitary cells. Adenoviral vectors offer a valuable tool for studies of gene regulation where conventional transgenesis and clonal cell lines are not available.


Subject(s)
Pituitary Gland, Anterior/metabolism , Prolactin/genetics , Promoter Regions, Genetic , Transcription, Genetic , Adenoviridae/genetics , Adolescent , Analysis of Variance , Cells, Cultured , Clone Cells , Colforsin/pharmacology , Gene Expression , Genetic Vectors/administration & dosage , Humans , Luciferases/genetics , Luminescent Measurements , Microscopy, Electron , Prolactin/metabolism , Transgenes
7.
J Neuroendocrinol ; 24(7): 977-90, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22420298

ABSTRACT

Transcription of numerous mammalian genes is highly pulsatile, with bursts of expression occurring with variable duration and frequency. The presence of this stochastic or 'noisy' expression pattern has been relatively unexplored in tissue systems. The prolactin gene provides a model of tissue-specific gene regulation resulting in pulsatile transcription dynamics in both cell lines and endocrine tissues. In most cell culture models, prolactin transcription appears to be highly variable between cells, with differences in transcription pulse duration and frequency. This apparently stochastic transcription is constrained by a transcriptional refractory period, which may be related to cycles of chromatin remodelling. We propose that prolactin transcription dynamics result from the summation of oscillatory cellular inputs and by regulation through chromatin remodelling cycles. Observations of transcription dynamics in cells within pituitary tissue show reduced transcriptional heterogeneity and can be grouped into a small number of distinct patterns. Thus, it appears that the tissue environment is able to reduce transcriptional noise to enable coordinated tissue responses to environmental change. We review the current knowledge on the complex tissue-specific regulation of the prolactin gene in pituitary and extra-pituitary sites, highlighting differences between humans and rodent experimental animal models. Within this context, we describe the transcription dynamics of prolactin gene expression and how this may relate to specific processes occurring within the cell.


Subject(s)
Gene Expression Regulation, Developmental , Prolactin/genetics , Animals , Genetic Loci/genetics , Humans , Models, Biological , Organ Specificity/genetics , Prolactin/metabolism , Time Factors , Tissue Distribution/genetics , Transcription Factors/metabolism , Transcription Factors/physiology , Transcription, Genetic/physiology
8.
Cell Death Dis ; 2: e136, 2011 Mar 31.
Article in English | MEDLINE | ID: mdl-21451571

ABSTRACT

The activation and regulation of target genes by the tumour-suppressor p53 dictates the fate of a cell, with cell cycle arrest or apoptosis being two distinct outcomes. PERP (p53 apoptosis effector related to PMP-22), a p53 transcriptional target, is induced specifically during apoptosis but not cell cycle arrest. Downregulation of PERP is associated with the aggressive, monosomy 3-type of uveal melanoma (UM), the most common primary intraocular tumour in adults, and increased PERP expression has a pro-apoptotic effect in UM cells. Here, we identify a novel effect of PERP expression, as elevated PERP protein positively influences active levels of its own transcriptional regulator, p53. Using fluorescent fusion proteins of PERP, p53 and MDM2, we demonstrate in single living UM cells that PERP expression significantly enhances p53 activity and its nuclear localization, increases p53-dependent transcription (including that of MDM2) while allowing oscillatory nucleo-cytoplasmic shuttling of p53/MDM2 complexes. Phosphorylation of p53 serine residues that interfere with the interaction between p53 and its negative regulator MDM2 and enhance pro-apoptotic gene transcription also occurs subsequent to PERP expression. These results implicate a role for PERP in amplifying functional p53 levels that promote p53-dependent apoptosis, and reveal a potential target for exploitation in enhancing p53 activity.


Subject(s)
Gene Expression Regulation , Membrane Proteins/metabolism , Proto-Oncogene Proteins c-mdm2/metabolism , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/metabolism , Apoptosis , Cell Line, Tumor , Genes, Tumor Suppressor , Humans , Melanoma/genetics , Melanoma/metabolism , Melanoma/physiopathology , Membrane Proteins/genetics , Phosphorylation , Protein Binding , Protein Stability , Proto-Oncogene Proteins c-mdm2/genetics , Tumor Suppressor Protein p53/genetics , Uveal Neoplasms/genetics , Uveal Neoplasms/metabolism , Uveal Neoplasms/physiopathology
9.
Cell Death Dis ; 1: e41, 2010 May 13.
Article in English | MEDLINE | ID: mdl-21364648

ABSTRACT

Medulloblastoma (MB) is an embryonic brain tumour that arises in the cerebellum. Using several MB cell lines, we have demonstrated that the chemotherapeutic drug etoposide induces a p53- and caspase-dependent cell death. We have observed an additional caspase-independent cell death mechanism involving delayed nuclear factor κB (NF-κB) activity. The delayed induction was controlled by a p53-dependent transcription step and the production of death receptors (especially CD95/Fas). We further demonstrated that in both MB and glioblastoma (GM) cell lines, in which the p53 pathway was not functional, no p65 activation could be detected upon etoposide treatment. MB cell lines that have mutations in p53 or NF-κB are either less sensitive (NF-κB mutant) or even completely resistant (p53 mutant) to chemotherapeutic intervention. The optimal cell death was only achieved when both p53 and NF-κB were switched on. Taken together, our results shed light on the mechanism of NF-κB activation by etoposide in brain tumours and show that the genetic background of MB and GM cells determines their sensitivity to chemotherapy and has to be taken into account for efficient therapeutic intervention.


Subject(s)
Cerebellar Neoplasms/pathology , Etoposide/pharmacology , Medulloblastoma/pathology , NF-kappa B/metabolism , Tumor Suppressor Protein p53/metabolism , Caspases/metabolism , Cell Death/drug effects , Cell Line, Tumor , Cerebellar Neoplasms/enzymology , Drug Screening Assays, Antitumor , Humans , Medulloblastoma/enzymology , Models, Biological , Phosphorylation/drug effects , Receptors, Death Domain/metabolism , Transcription Factor RelA/metabolism
10.
Biochem Soc Trans ; 35(Pt 2): 263-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17371255

ABSTRACT

The transcription factor NF-kappaB (nuclear factor kappaB) regulates critical cellular processes including the inflammatory response, apoptosis and the cell cycle. Over the past 20 years many of the components of the NF-kappaB signalling pathway have been elucidated along with their functions. Recent research in this field has focused on the dynamic regulation and network control of this system. With key roles in so many important cellular processes, it is critical that NF-kappaB signalling is tightly regulated. Recently, single-cell imaging and mathematical modelling have identified that the timing of cellular responses may play an important role in the regulation of this pathway. p65/RelA (RelA) has been shown to translocate between the nucleus and cytoplasm with varying oscillatory patterns in different cell lines leading to differences in transcriptional outputs from NF-kappaB-regulated genes. Variations in the timing or persistence of these movements may control the maintenance and differential expression of NF-kappaB-regulated genes.


Subject(s)
I-kappa B Proteins/physiology , NF-kappa B/physiology , HeLa Cells , Humans , Kinetics , NF-KappaB Inhibitor alpha , NF-kappa B/antagonists & inhibitors , Oscillometry , Protein Processing, Post-Translational , Signal Transduction , Tumor Necrosis Factor-alpha/physiology
11.
Am J Physiol Lung Cell Mol Physiol ; 291(4): L559-65, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16603591

ABSTRACT

Prenatal airway smooth muscle (ASM) peristalsis appears coupled to lung growth. Moreover, ASM progenitors produce fibroblast growth factor-10 (FGF-10) for lung morphogenesis. Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, FGF-10 deficiency, and postnatal ASM dysfunction. We hypothesized ASM dysfunction emerges in tandem with, and may contribute toward, the primordial lung hypoplasia that precedes experimental CDH. Spatial origin and frequency of ASM peristaltic waves were measured in normal and hypoplastic rat lungs cultured from day 13.5 of gestation (lung hypoplasia was generated by nitrofen dosing of pregnant dams). Longitudinal lung growth was assayed by bud counts and tracing photomicrographs of cultures. Coupling of lung growth and peristalsis was tested by stimulation studies using serum, FGF-10, or nicotine and inhibition studies with nifedipine or U0126 (MEK1/2 inhibitor). In normal lung, ASM peristalsis is developmentally regulated: proximal ASM becomes quiescent (while retaining capacity for cholinergic-stimulated peristalsis). However, in hypoplastic lung, spontaneous proximal ASM activity persists. FGF-10 corrects this aberrant ASM activity in tandem with improved growth. Stimulation and inhibition studies showed that, unlike normal lung, changes in growth or peristalsis are not consistently accompanied by parallel modulation of the other. ASM peristalsis undergoes FGF-10-regulated spatiotemporal development coupled to lung growth: this process is disrupted early in lung hypoplasia. ASM dysfunction emerges in tandem with and may therefore contribute toward lung hypoplasia in CDH.


Subject(s)
Lung/abnormalities , Lung/embryology , Muscle Contraction , Muscle Development/physiology , Muscle, Smooth/embryology , Respiratory System/embryology , Animals , Embryo, Mammalian/drug effects , Embryo, Mammalian/physiology , Embryonic Development , Female , Fibroblast Growth Factor 10/pharmacology , Hernia, Diaphragmatic/complications , Hernias, Diaphragmatic, Congenital , In Vitro Techniques , Muscle Contraction/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Respiratory System Abnormalities/complications , Respiratory System Abnormalities/embryology
12.
Syst Biol (Stevenage) ; 152(3): 153-60, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16986278

ABSTRACT

In previous work, we studied the behaviour of a model of part of the NF-kappaB signalling pathway. The model displayed oscillations that varied both in number, amplitude and frequency when its parameters were varied. Sensitivity analysis showed that just nine of the 64 reaction parameters were mainly responsible for the control of the oscillations when these parameters were varied individually. However, the control of the properties of any complex system is distributed, and, as many of these reactions are highly non-linear, we expect that their interactions will be too. Pairwise modulation of these nine parameters gives a search space some 50 times smaller (81 against 4096) than that required for the pairwise modulation of all 64 reactions, and this permitted their study (which would otherwise have been effectively intractable). Strikingly synergistic effects were observed, in which the effect of one of the parameters was strongly (and even qualitatively) dependent on the values of another parameter. Regions of parameter space could be found in which the amplitude, but not the frequency (timing), of oscillations varied, and vice versa. Such modelling will permit the design and performance of experiments aimed at disentangling the role of the dynamics of oscillations, rather than simply their amplitude, in determining cell fate. Overall, the analyses reveal a level of complexity in these dynamic models that is not apparent from study of their individual parameters alone and point to the value of manipulating multiple elements of complex networks to achieve desired physiological effects.


Subject(s)
Biological Clocks/physiology , Cell Physiological Phenomena , Models, Biological , NF-kappa B/metabolism , Signal Transduction/physiology , Animals , Computer Simulation , Feedback/physiology , Gene Expression Regulation/physiology , Humans
13.
Biochem Soc Trans ; 32(Pt 6): 1090-2, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15506974

ABSTRACT

Oscillations in second-messenger signalling (e.g. calcium) have previously been shown to be important in the control of transcription. More recently, oscillations in localization and absolute levels of transcription factors and their regulators have been identified. Here we discuss the role of network motifs such as the negative feedback loop and their role in oscillatory signalling, and how oscillations in components of the nuclear factor kappaB signalling pathway are important to the dynamic control of transcription in response to a cytokine stimulus.


Subject(s)
Gene Expression Regulation/physiology , Transcription Factors/metabolism , Animals , Feedback , Kinetics , Models, Genetic , NF-kappa B/physiology , Oscillometry
14.
Science ; 306(5696): 704-8, 2004 Oct 22.
Article in English | MEDLINE | ID: mdl-15499023

ABSTRACT

Signaling by the transcription factor nuclear factor kappa B (NF-kappaB) involves its release from inhibitor kappa B (IkappaB) in the cytosol, followed by translocation into the nucleus. NF-kappaB regulation of IkappaBalpha transcription represents a delayed negative feedback loop that drives oscillations in NF-kappaB translocation. Single-cell time-lapse imaging and computational modeling of NF-kappaB (RelA) localization showed asynchronous oscillations following cell stimulation that decreased in frequency with increased IkappaBalpha transcription. Transcription of target genes depended on oscillation persistence, involving cycles of RelA phosphorylation and dephosphorylation. The functional consequences of NF-kappaB signaling may thus depend on number, period, and amplitude of oscillations.


Subject(s)
Gene Expression Regulation , NF-kappa B/metabolism , Signal Transduction , Active Transport, Cell Nucleus , Cell Line, Tumor , Cell Nucleus/metabolism , Computer Simulation , Cytoplasm/metabolism , Etoposide/pharmacology , Feedback, Physiological , HeLa Cells , Humans , I-kappa B Proteins/genetics , I-kappa B Proteins/metabolism , Models, Biological , NF-KappaB Inhibitor alpha , Phosphorylation , Recombinant Fusion Proteins/metabolism , Transcription Factor RelA , Transcription, Genetic , Transfection , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL